Publikationen von Tiago F. Outeiro
Alle Typen
Zeitschriftenartikel (94)
61.
Zeitschriftenartikel
37 (1), S. 139 - 159 (2018)
Glyoxal as an alternative fixative to formaldehyde in immunostaining and super-resolution microscopy. EMBO Journal 62.
Zeitschriftenartikel
55, S. 5269 - 5281 (2018)
Implications of fALS mutations on Sod1 function and oligomerization in cell models. Molecular Neurobiology 63.
Zeitschriftenartikel
5 (1), S. 4 - 31 (2018)
Guidelines and recommendations on yeast cell death nomenclature. Microbial Cell 64.
Zeitschriftenartikel
8 (1), S. 33 - 43 (2018)
Alpha-synuclein glycation and the action of anti-diabetic agents in Parkinson's disease. Journal of Parkinson's Disease: JPD 65.
Zeitschriftenartikel
119, S. 121 - 135 (2018)
Alpha-synuclein deregulates the expression of COL4A2 and impairs ER-Golgi function. Neurobiology of Disease 66.
Zeitschriftenartikel
115 (41), S. 10481 - 10486 (2018)
Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Proceedings of the National Academy of Sciences of the United States of America 67.
Zeitschriftenartikel
9, 97 (2017)
The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome 68.
Zeitschriftenartikel
20 (11), S. 1569 - 1579 (2017)
Alpha-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B. Nature Neuroscience 69.
Zeitschriftenartikel
7, 13713 (2017)
Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease. Scientific Reports 70.
Zeitschriftenartikel
32 (9), S. 1331 - 1333 (2017)
Neuromelanin magnetic resonance imaging of the Substantia Nigra in LRRK2-related Parkinson's disease. Movement Disorders 71.
Zeitschriftenartikel
295, S. 77 - 87 (2017)
Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease. Experimental Neurology 72.
Zeitschriftenartikel
56, S. 7 - 16 (2017)
Sirtuin 2 enhances dopaminergic differentiation via the AKT/GSK-3β/β-catenin pathway. Neurobiology of Aging 73.
Zeitschriftenartikel
73 (4), S. 459 - 467 (2017)
IGF-I gene therapy in aging rats modulates hippocampal genes relevant to memory function. Journals of Gerontology: Series A, Biological Sciences and Medical Sciences 74.
Zeitschriftenartikel
26 (12), S. 2231 - 2246 (2017)
Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Human Molecular Genetics 75.
Zeitschriftenartikel
114 (25), S. E4971 - E4977 (2017)
Treatment with diphenyl-pyrazole compound anle138b/c reveals that alpha-synuclein protects melanoma cells from autophagic cell death. Proceedings of the National Academy of Sciences of the United States of America 76.
Zeitschriftenartikel
114 (25), S. E4971 - E4977 (2017)
Treatment with diphenyl–pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death. Proceedings of the National Academy of Sciences of the United States of America 77.
Zeitschriftenartikel
140, S. 1399 - 1419 (2017)
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies. Brain 78.
Zeitschriftenartikel
140, S. 878 - 886 (2017)
The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease. Brain 79.
Zeitschriftenartikel
15 (3), e1002601 (2017)
The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biology 80.
Zeitschriftenartikel
7, 42942 (2017)
Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress. Scientific Reports